ANDREA DAMERON: Open Payments
NPI 1689878795 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$183 in 8 payments from 5 companies in 2025. Trend: 2023 $366 · 2024 $359 · 2025 $183
Food & beverage: $183
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 4 | $106 |
| Eisai Inc. | 1 | $22 |
| AstraZeneca Pharmaceuticals LP | 1 | $22 |
| GlaxoSmithKline, LLC. | 1 | $21 |
| Molnlycke Health Care US, LLC | 1 | $13 |
Products named: LYNPARZA, KEYTRUDA, Lenvima, JEMPERLI, Mepilex Border Post-Op Ag.
Industry payments across GA — which companies pay providers there.
